Literature DB >> 33859174

FCN3 functions as a tumor suppressor of lung adenocarcinoma through induction of endoplasmic reticulum stress.

Haeyeon Jang1,2, Yukyung Jun3,4, Suyeon Kim1,2, Eunjeong Kim1,2, Yeonjoo Jung1,2, Byung Jo Park5, Jinseon Lee6, Jhingook Kim5, Sanghyuk Lee7,8,9, Jaesang Kim10,11,12.   

Abstract

In this study, we report a novel function of FCN3 (Ficolin 3), a secreted lectin capable of activating the complement pathway, as a tumor suppressor of lung adenocarcinoma (LUAD). First, the expression of FCN3 was strongly down-regulated in cancer tissues compared to matched normal lung tissues, and down-regulation of FCN3 was shown to be significantly correlated with increased mortality among LUAD patients. Interestingly, while ectopic expression of FCN3 led to cell cycle arrest and apoptosis in A549 and H23 cells derived from LUAD, the secreted form of the protein had no effect on the cells. Rather, we found evidence indicating that activation of the unfolded protein response from endoplasmic reticulum (ER) stress is induced by ectopic expression of FCN3. Consistently, inhibition of ER stress response led to enhanced survival of the LUAD cells. Of note, the fibrinogen domain, which is not secreted, turned out to be both necessary and sufficient for induction of apoptosis when localized to ER, consistent with our proposed mechanism. Collectively, our data indicate that FCN3 is a tumor suppressor gene functioning through induction of ER stress.

Entities:  

Year:  2021        PMID: 33859174     DOI: 10.1038/s41419-021-03675-y

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  6 in total

1.  A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma.

Authors:  Xing Lai; Ya-Kun Wu; Guo-Qing Hong; Jun-Ke Li; Qing Luo; Jin Yuan; Guo-Hua Dai; Shuang-Quan Liu; Hua-Guo Feng
Journal:  J Immunol Res       Date:  2022-03-30       Impact factor: 4.818

2.  USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction.

Authors:  Mi-Jeong Kim; Yoon Min; Soo-Kyung Jeong; Juhee Son; Ji Young Kim; Ji Su Lee; Duk-Hwan Kim; Joo Sang Lee; Eunyoung Chun; Ki-Young Lee
Journal:  Cell Death Dis       Date:  2022-04-14       Impact factor: 9.685

3.  Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis.

Authors:  Beatriz Andrea Otálora-Otálora; Daniel Alejandro Osuna-Garzón; Michael Steven Carvajal-Parra; Alejandra Cañas; Martín Montecino; Liliana López-Kleine; Adriana Rojas
Journal:  Biology (Basel)       Date:  2022-07-20

4.  Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma.

Authors:  Liang Sun; Shian Yu; Cairong Dong; Zhengyi Wu; He Huang; Zhendong Chen; Zhipeng Wu; Xiangbao Yin
Journal:  Front Genet       Date:  2022-07-19       Impact factor: 4.772

5.  Endoplasmic Reticulum Stress-Related Signature for Predicting Prognosis and Immune Features in Hepatocellular Carcinoma.

Authors:  Genhao Zhang; Jianping Sun
Journal:  J Immunol Res       Date:  2022-08-14       Impact factor: 4.493

Review 6.  Components of the Lectin Pathway of Complement in Solid Tumour Cancers.

Authors:  Maciej Cedzyński; Anna S Świerzko
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.